Accepted for/Published in: JMIR Research Protocols
Date Submitted: Apr 10, 2019
Open Peer Review Period: Apr 23, 2019 - May 7, 2019
Date Accepted: Jul 19, 2019
(closed for review but you can still tweet)
Weight-loss after stroke: A randomized controlled trial protocol for an intensive lifestyle intervention (GLB-CVA).
ABSTRACT
Background:
Weight gain can be a consequence of stroke, or cerebrovascular accident (CVA), due to impaired mobility, behavioral and emotional disorder, and sensory losses. Weight gain increases the patient’s risk of recurrent stroke and chronic diseases such as diabetes, metabolic syndrome, pulmonary and heart disease. Approaches to weight loss in this population are lacking, yet necessary, due to the unique physiological and cognitive needs of persons post stroke. Evidence demonstrates that intensive behavioral therapy interventions that address both physical activity and diet offer the greatest potential for weight-loss. The Group Lifestyle Balance (GLB) intervention is a twelve-month, evidence-based weight-loss program that has been used extensively with the general population, but not with people post stroke. We modified the program to meet the needs of people who have a stroke (GLB-CVA).
Objective:
This current randomized control trial (RCT) examines the efficacy of the GLB-CVA on weight and secondary outcomes compared to a waitlist controlled group.
Methods:
This RCT will enroll and randomize 64 patients over an eighteen-month period.
Results:
N/A
Conclusions:
It is anticipated the findings from this RCT will contribute to the evidence base regarding weight-loss strategies for people living with stroke. Clinical Trial: NCT03873467
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.